Damon Runyon is excited to announce the election of Joseph Pearlberg, MD, PhD, to its Board of Directors.

Dr. Pearlberg is Vice President of Scientific Affairs on the Therapeutics Team at Deerfield Management Company, an investment firm dedicated to advancing healthcare through information, investment, and philanthropy. Formerly Vice President of Clinical Development at Infinity Pharmaceuticals and a Medical Director in the oncology unit of Sanofi, Dr. Pearlberg brings experience from both the pharmaceutical and biotechnologies industries. Dr. Pearlberg received his M.D. from the University of California, San Francisco, and holds a Ph.D. in Molecular Biology from Harvard University.

We welcome Dr. Pearlberg to the Board and look forward to working with him.